Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG
| Report ID | 127123 |
| Drug Identification Number | 02243562 |
| Brand name | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG |
| Common or Proper name | NHYDROMORPH CONTIN |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 18MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-11-06 |
| Actual start date | 2020-11-16 |
| Estimated end date | 2020-11-30 |
| Actual end date | 2020-11-26 |
| Shortage status | Resolved |
| Updated date | 2020-12-01 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 575 GRANITE COURT PICKERING, ONTARIO CANADA L1W 3W8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.